Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000935
Chunk: 10

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 10
---
 split, Depositary Share-Ordinary Share ratio change or other similar transaction).

(l) “” means the United Kingdom Companies Act 2006.

(m) “” means any information disclosed by either party to the other party, either directly or indirectly, in writing,
orally or by inspection of tangible objects (including, without limitation, documents, prototypes, samples, plant and equipment), which
is designated as “Confidential,” “Proprietary” or some similar designation. Information communicated orally shall
be considered Confidential Information if such information is confirmed in writing as being Confidential Information within ten (10) Business
Days after the initial disclosure. Confidential Information may also include information disclosed to a disclosing party by third parties.
Confidential Information shall not, however, include any information which (i) was publicly known and made generally available in the
public domain prior to the time of disclosure by the disclosing party; (ii) becomes publicly known and made generally available after
disclosure by the disclosing party to the receiving party through no action or inaction of the receiving party; (iii) is already in the
possession of the receiving party without confidential restriction at the time of disclosure by the disclosing party as shown by the receiving
party’s files and records immediately prior to the time of disclosure; (iv) is obtained by the receiving party from a third party
without a breach of such third party’s obligations of confidentiality; (v) is independently developed by the receiving party without
use of or reference to the disclosing party’s Confidential Information, as shown by documents and other competent evidence in the
receiving party’s possession; or (vi) is required by law to be disclosed by the receiving party, provided that (X) the receiving
party (1) gives the disclosing party prompt written notice of such requirement prior to such disclosure and assistance in obtaining an
order protecting the information from public disclosure and (2) furnishes only that portion of the Confidential Information that is legally
required to be disclosed, and (Y) any Confidential Information so disclosed shall maintain its confidentiality protection for all purposes
other than such legally required disclosure.

(n) “”
means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.

(o) “” means the Second Amended and Restated Deposit Agreement by and among the Company, JPMorgan Chase Bank, N.A., as depositary,
and all owners and holders from time to time of American Depositary Shares thereunder.

(p) “”
means JPMorgan